Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07346170 · ClinicalTrials.gov registry record · NA
Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07346170 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 50 participants.
The verdict
NCT07346170, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Current guidelines suggest postoperative spine Stereotactic Body Radiation Therapy (SBRT) should be delivered within 2-4 weeks after surgery. This approach is rife with logistical complications that create delays and barriers for patients accessing care. An alternative approach delivers postoperative spine SBRT soon after surgery, starting within a single hospital stay. This study will investigate the effects of short-term postoperative spine SBRT on wound complications in a safety lead-in, then will transition to a phase 2 trial investigating local tumor control.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- BEHAVIORAL Questionnaires
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- PROCEDURE Computed Tomography (CT) Simulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07346170
The ClinicalTrials.gov registry entry for NCT07346170 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT07346170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07346170 about?
NCT07346170 is a clinical study titled "Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases". Current guidelines suggest postoperative spine Stereotactic Body Radiation Therapy (SBRT) should be delivered within 2-4 weeks after surgery. This approach is rife with logistical complications that create delays and barriers for patients accessing care. An alternative approach delivers postoperativ...
What is the current status of trial NCT07346170?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-15. Estimated completion is 2027-10-31.
What interventions are being tested in trial NCT07346170?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Questionnaires (BEHAVIORAL), Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Computed Tomography (CT) Simulation (PROCEDURE).
Who is sponsoring clinical trial NCT07346170?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.